Annual FCF
-$36.91 M
-$8.60 M-30.38%
December 31, 2023
Summary
- As of February 8, 2025, SLS annual free cash flow is -$36.91 million, with the most recent change of -$8.60 million (-30.38%) on December 31, 2023.
- During the last 3 years, SLS annual FCF has fallen by -$26.49 million (-254.32%).
- SLS annual FCF is now -1647.63% below its all-time high of -$2.11 million, reached on December 31, 2006.
Performance
SLS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$7.81 M
+$1.88 M+19.38%
September 30, 2024
Summary
- As of February 8, 2025, SLS quarterly free cash flow is -$7.81 million, with the most recent change of +$1.88 million (+19.38%) on September 30, 2024.
- Over the past year, SLS quarterly FCF has dropped by -$2.98 million (-61.78%).
- SLS quarterly FCF is now -131.14% below its all-time high of $25.07 million, reached on December 31, 2016.
Performance
SLS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$33.07 M
+$2.09 M+5.93%
September 30, 2024
Summary
- As of February 8, 2025, SLS TTM free cash flow is -$33.07 million, with the most recent change of +$2.09 million (+5.93%) on September 30, 2024.
- Over the past year, SLS TTM FCF has increased by +$3.84 million (+10.39%).
- SLS TTM FCF is now -650.22% below its all-time high of $6.01 million, reached on June 30, 2017.
Performance
SLS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SLS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.4% | -61.8% | +10.4% |
| 3 y3 years | -254.3% | +22.4% | +0.1% |
| 5 y5 years | -21.3% | +22.4% | +0.1% |
SLS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -41.9% | at low | -61.8% | +35.6% | -44.4% | +11.2% |
| 5 y | 5-year | -254.3% | at low | -328.0% | +35.6% | -217.5% | +11.2% |
| alltime | all time | -1647.6% | +23.6% | -131.1% | +59.7% | -650.2% | +36.7% |
SELLAS Life Sciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.81 M(-19.4%) | -$33.07 M(-5.9%) |
| Jun 2024 | - | -$9.68 M(-10.0%) | -$35.16 M(-1.1%) |
| Mar 2024 | - | -$10.76 M(+123.0%) | -$35.54 M(-3.7%) |
| Dec 2023 | -$36.91 M(+30.4%) | -$4.83 M(-51.2%) | -$36.91 M(-0.9%) |
| Sep 2023 | - | -$9.89 M(-1.7%) | -$37.24 M(+12.5%) |
| Jun 2023 | - | -$10.07 M(-17.0%) | -$33.09 M(-0.6%) |
| Mar 2023 | - | -$12.13 M(+135.4%) | -$33.29 M(+17.6%) |
| Dec 2022 | -$28.31 M(+8.8%) | -$5.15 M(-10.3%) | -$28.31 M(+0.6%) |
| Sep 2022 | - | -$5.75 M(-44.0%) | -$28.13 M(-0.5%) |
| Jun 2022 | - | -$10.26 M(+43.5%) | -$28.27 M(+23.4%) |
| Mar 2022 | - | -$7.15 M(+43.7%) | -$22.90 M(-12.0%) |
| Dec 2021 | -$26.02 M(+149.8%) | -$4.98 M(-15.3%) | -$26.02 M(+47.7%) |
| Sep 2021 | - | -$5.88 M(+20.0%) | -$17.62 M(+14.6%) |
| Jun 2021 | - | -$4.90 M(-52.3%) | -$15.37 M(+10.9%) |
| Mar 2021 | - | -$10.27 M(-399.9%) | -$13.86 M(+33.0%) |
| Dec 2020 | -$10.42 M(-41.0%) | $3.42 M(-194.4%) | -$10.42 M(-42.2%) |
| Sep 2020 | - | -$3.63 M(+7.3%) | -$18.02 M(-1.0%) |
| Jun 2020 | - | -$3.38 M(-50.5%) | -$18.21 M(-6.5%) |
| Mar 2020 | - | -$6.83 M(+63.6%) | -$19.48 M(+10.4%) |
| Dec 2019 | -$17.64 M(-42.0%) | -$4.18 M(+9.3%) | -$17.64 M(-2.1%) |
| Sep 2019 | - | -$3.82 M(-18.0%) | -$18.02 M(-36.5%) |
| Jun 2019 | - | -$4.66 M(-6.7%) | -$28.37 M(-5.5%) |
| Mar 2019 | - | -$4.99 M(+9.6%) | -$30.01 M(-1.4%) |
| Dec 2018 | -$30.42 M(+176.8%) | -$4.55 M(-67.8%) | -$30.42 M(+186.5%) |
| Sep 2018 | - | -$14.16 M(+124.9%) | -$10.62 M(-33.0%) |
| Jun 2018 | - | -$6.30 M(+16.6%) | -$15.84 M(+25.8%) |
| Mar 2018 | - | -$5.40 M(-135.4%) | -$12.59 M(+14.6%) |
| Dec 2017 | -$10.99 M(-7.3%) | $15.25 M(-178.7%) | -$10.99 M(+841.6%) |
| Sep 2017 | - | -$19.39 M(+535.8%) | -$1.17 M(-119.4%) |
| Jun 2017 | - | -$3.05 M(-19.8%) | $6.01 M(-347.3%) |
| Mar 2017 | - | -$3.80 M(-115.2%) | -$2.43 M(-79.5%) |
| Dec 2016 | -$11.85 M(-75.5%) | $25.07 M(-305.4%) | -$11.85 M(-77.3%) |
| Sep 2016 | - | -$12.21 M(+6.2%) | -$52.28 M(+5.4%) |
| Jun 2016 | - | -$11.49 M(-13.1%) | -$49.58 M(-0.8%) |
| Mar 2016 | - | -$13.22 M(-13.9%) | -$49.96 M(+3.4%) |
| Dec 2015 | -$48.31 M | -$15.36 M(+61.5%) | -$48.31 M(+10.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$9.51 M(-19.9%) | -$43.80 M(-3.6%) |
| Jun 2015 | - | -$11.88 M(+2.6%) | -$45.43 M(-3.0%) |
| Mar 2015 | - | -$11.57 M(+6.7%) | -$46.84 M(+3.3%) |
| Dec 2014 | -$45.34 M(+55.0%) | -$10.84 M(-2.6%) | -$45.34 M(+38.7%) |
| Sep 2014 | - | -$11.13 M(-16.2%) | -$32.68 M(+10.3%) |
| Jun 2014 | - | -$13.28 M(+31.8%) | -$29.63 M(+23.9%) |
| Mar 2014 | - | -$10.08 M(-654.8%) | -$23.91 M(-18.2%) |
| Dec 2013 | -$29.25 M(+39.5%) | $1.82 M(-122.5%) | -$29.25 M(-19.3%) |
| Sep 2013 | - | -$8.08 M(+6.7%) | -$36.24 M(+12.1%) |
| Jun 2013 | - | -$7.57 M(-50.9%) | -$32.33 M(+2.6%) |
| Mar 2013 | - | -$15.42 M(+197.7%) | -$31.50 M(+50.2%) |
| Dec 2012 | -$20.97 M(+42.5%) | -$5.18 M(+24.3%) | -$20.97 M(+5.1%) |
| Sep 2012 | - | -$4.17 M(-38.3%) | -$19.96 M(+3.9%) |
| Jun 2012 | - | -$6.75 M(+38.1%) | -$19.21 M(+16.2%) |
| Mar 2012 | - | -$4.88 M(+17.2%) | -$16.54 M(+12.3%) |
| Dec 2011 | -$14.72 M(+42.1%) | -$4.17 M(+22.2%) | -$14.72 M(+18.1%) |
| Sep 2011 | - | -$3.41 M(-16.2%) | -$12.46 M(+10.3%) |
| Jun 2011 | - | -$4.07 M(+32.8%) | -$11.30 M(+3.0%) |
| Mar 2011 | - | -$3.07 M(+60.6%) | -$10.97 M(+5.9%) |
| Dec 2010 | -$10.36 M(-12.6%) | -$1.91 M(-15.0%) | -$10.36 M(-11.7%) |
| Sep 2010 | - | -$2.25 M(-40.0%) | -$11.74 M(-6.6%) |
| Jun 2010 | - | -$3.75 M(+52.4%) | -$12.57 M(+8.1%) |
| Mar 2010 | - | -$2.46 M(-25.2%) | -$11.63 M(-1.9%) |
| Dec 2009 | -$11.85 M(+23.5%) | -$3.29 M(+6.8%) | -$11.85 M(+4.0%) |
| Sep 2009 | - | -$3.08 M(+9.8%) | -$11.39 M(+6.8%) |
| Jun 2009 | - | -$2.80 M(+4.6%) | -$10.67 M(+0.7%) |
| Mar 2009 | - | -$2.68 M(-5.3%) | -$10.59 M(+10.4%) |
| Dec 2008 | -$9.60 M(+52.9%) | -$2.83 M(+20.1%) | -$9.60 M(+5.1%) |
| Sep 2008 | - | -$2.35 M(-13.6%) | -$9.13 M(+1.9%) |
| Jun 2008 | - | -$2.73 M(+61.6%) | -$8.96 M(+29.8%) |
| Mar 2008 | - | -$1.69 M(-28.7%) | -$6.90 M(+9.9%) |
| Dec 2007 | -$6.28 M(+197.2%) | -$2.36 M(+8.3%) | -$6.28 M(+60.4%) |
| Sep 2007 | - | -$2.18 M(+227.0%) | -$3.91 M(+125.9%) |
| Jun 2007 | - | -$667.00 K(-37.4%) | -$1.73 M(+62.6%) |
| Mar 2007 | - | -$1.06 M | -$1.06 M |
| Dec 2006 | -$2.11 M | - | - |
FAQ
- What is SELLAS Life Sciences annual free cash flow?
- What is the all time high annual FCF for SELLAS Life Sciences?
- What is SELLAS Life Sciences annual FCF year-on-year change?
- What is SELLAS Life Sciences quarterly free cash flow?
- What is the all time high quarterly FCF for SELLAS Life Sciences?
- What is SELLAS Life Sciences quarterly FCF year-on-year change?
- What is SELLAS Life Sciences TTM free cash flow?
- What is the all time high TTM FCF for SELLAS Life Sciences?
- What is SELLAS Life Sciences TTM FCF year-on-year change?
What is SELLAS Life Sciences annual free cash flow?
The current annual FCF of SLS is -$36.91 M
What is the all time high annual FCF for SELLAS Life Sciences?
SELLAS Life Sciences all-time high annual free cash flow is -$2.11 M
What is SELLAS Life Sciences annual FCF year-on-year change?
Over the past year, SLS annual free cash flow has changed by -$8.60 M (-30.38%)
What is SELLAS Life Sciences quarterly free cash flow?
The current quarterly FCF of SLS is -$7.81 M
What is the all time high quarterly FCF for SELLAS Life Sciences?
SELLAS Life Sciences all-time high quarterly free cash flow is $25.07 M
What is SELLAS Life Sciences quarterly FCF year-on-year change?
Over the past year, SLS quarterly free cash flow has changed by -$2.98 M (-61.78%)
What is SELLAS Life Sciences TTM free cash flow?
The current TTM FCF of SLS is -$33.07 M
What is the all time high TTM FCF for SELLAS Life Sciences?
SELLAS Life Sciences all-time high TTM free cash flow is $6.01 M
What is SELLAS Life Sciences TTM FCF year-on-year change?
Over the past year, SLS TTM free cash flow has changed by +$3.84 M (+10.39%)